The DNAJB9 Knockout A-549 Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout cell population, designed to disrupt the DNAJB9 gene in A-549 human lung adenocarcinoma cells. This heterogeneous knockout pool circumvents clonal variation and provides a consistent loss-of-function model for investigating endoplasmic reticulum (ER) stress, unfolded protein response (UPR), and chaperone biology without the need for continuous selection.
A-549 cells, derived from a human lung adenocarcinoma, display epithelial morphology and serve as a standard model for type II alveolar epithelium. Widely used in respiratory disease and oncology research, these cells recapitulate key aspects of non-small cell lung cancer, including drug sensitivity and metastatic potential. Their well-characterized transcriptome and signaling networks make them an ideal host for studying the role of ER stress regulators in lung cancer progression and therapy resistance.
The DNAJB9 protein (ERdj4) is an ER-resident co-chaperone that binds misfolded substrates and targets them for ER-associated degradation (ERAD), functioning as a negative regulator of ER stress-induced apoptosis. Transcriptionally induced by ATF6 and XBP1 under stress, DNAJB9 interacts with BIP/GRP78, IRE1??, Derlin-1, and VIMP to modulate IRE1?? signaling and suppress CHOP/DDIT3-dependent cell death. Thus, DNAJB9 fine-tunes the UPR by promoting protein quality control while preventing excessive apoptotic signaling.
In the A-549 context, DNAJB9 knockout likely disrupts ERAD-mediated cytoprotection, sensitizing cells to ER stress inducers such as tunicamycin or thapsigargin. This model is pivotal for dissecting the UPR’s role in lung adenocarcinoma survival, particularly under therapeutic stress. It enables examination of how IRE1?? pathway attenuation contributes to drug resistance and provides a platform for identifying synthetic lethal interactions with proteasome inhibitors or ER stress modulators.
Researchers can employ these cells for western blot analysis of GRP78 and CHOP, RT-qPCR of XBP1 mRNA splicing, flow cytometry-based apoptosis assessment, and cell viability assays under ER stress. Co-immunoprecipitation and RNA-seq studies can probe DNAJB9’s interaction network and global UPR transcriptional changes. Additional assays, such as migration and invasion tests, allow the study of ER stress-related metastatic behavior. For further technical information, please contact Ascent Research.
